BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18067015)

  • 1. Birth order pattern in the inheritance of chronic lymphocytic leukaemia and related lymphoproliferative disease.
    Jønsson V; Tjønnfjord G; Samuelsen SO; Johannesen T; Olsen J; Sellick G; Houlston R; Yuille M; Catovsky D
    Leuk Lymphoma; 2007 Dec; 48(12):2387-96. PubMed ID: 18067015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial chronic lymphocytic leukemia in Norway and Denmark. Comments on pleiotropy and birth order.
    Jønsson V; Tjønnfjord GE; Johannesen TB; Ly B; Olsen JH; Yuille M
    In Vivo; 2010; 24(1):85-95. PubMed ID: 20133982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial occurrence of chronic lymphocytic leukaemia in Norway.
    Tjønnfjord GE; Jønsson V; Ly BE; Johannesen TB
    Tidsskr Nor Laegeforen; 2012 Oct; 132(18):2060-3. PubMed ID: 23038196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inheritance in lymphoproliferative disorders].
    Jønsson V; Olsen JH
    Ugeskr Laeger; 2006 Jun; 168(24):2361-6. PubMed ID: 16822421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours.
    Goldin LR; Caporaso NE
    Br J Haematol; 2007 Dec; 139(5):774-9. PubMed ID: 18021091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meiotic drive in chronic lymphocytic leukemia compared with other malignant blood disorders.
    Jønsson V; Awan H; Jones ND; Johannesen TB; Thøgersen K; Steig BÁ; Andorsdottir G; Tjønnfjord GE
    Sci Rep; 2022 Apr; 12(1):6138. PubMed ID: 35413962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of lymphoproliferative disorders in relatives of patients with B-cell chronic lymphocytic leukemia: relevance of the degree of familial linkage.
    Capalbo S; Trerotoli P; Ciancio A; Battista C; Serio G; Liso V
    Eur J Haematol; 2000 Aug; 65(2):114-7. PubMed ID: 10966171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible imprinting and microchimerism in chronic lymphocytic leukemia and related lymphoproliferative disorders.
    Jønsson V; Tjønnfjord GE; Johannesen TB; Samuelsen SO; Ly B
    Transl Oncogenomics; 2008 Feb; 3():15-20. PubMed ID: 21566740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline copy number variation associated with Mendelian inheritance of CLL in two families.
    Brown JR; Hanna M; Tesar B; Pochet N; Vartanov A; Fernandes SM; Werner L; Ash M; Roden CA; MacConaill L; Hainz U; Longtine J; Wang YE; Correll M; Van de Peer Y; Regev A; Wu C; Neuberg D; Freedman AS
    Leukemia; 2012 Jul; 26(7):1710-3. PubMed ID: 22382893
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticipation in families with chronic lymphocytic leukemia and other lymphoproliferative disorders.
    Awan H; Jønsson V; Johannesen TB; Ly B; Tjønnfjord GE
    Transl Oncogenomics; 2010 Mar; 4():1-9. PubMed ID: 21566766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Hodgkin's lymphoma in Scandinavia.
    Jønsson V; Awan H; Nyquist E; Maisenhølder M; Johannesen TB; Ly B; Tjønnfjord GE
    In Vivo; 2011; 25(3):431-7. PubMed ID: 21576419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In non-follicular lymphoproliferative disorders, IGH/BCL2-fusion is not restricted to chronic lymphocytic leukaemia.
    Baseggio L; Geay MO; Gazzo S; Berger F; Traverse-Glehen A; Ffrench M; Hayette S; Callet-Bauchu E; Verney A; Morel D; Jallades L; Magaud JP; Salles G; Felman P
    Br J Haematol; 2012 Aug; 158(4):489-98. PubMed ID: 22686190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
    Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticipation in familial chronic lymphocytic leukaemia.
    Yuille MR; Houlston RS; Catovsky D
    Leukemia; 1998 Nov; 12(11):1696-8. PubMed ID: 9823943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders.
    Musolino C; Allegra A; Penna G; Centorrino R; Cuzzola M; D'Angelo A; Iacopino P; Alonci A
    Acta Haematol; 2009; 122(1):46-9. PubMed ID: 19816006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial chronic lymphocytic leukaemia: a survey and review of published studies.
    Yuille MR; Matutes E; Marossy A; Hilditch B; Catovsky D; Houlston RS
    Br J Haematol; 2000 Jun; 109(4):794-9. PubMed ID: 10929032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a clinically relevant cytogenetic classification of chronic lymphocytic leukemia and related disorders.
    Cuneo A; Bigoni R; Castoldi G
    Haematologica; 1998 Jul; 83(7):577-9. PubMed ID: 9718860
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia.
    Bogunia-Kubik K; Mazur G; Urbanowicz I; Wróbel T; Kuliczkowski K; Woźniak M; Lange A
    Int J Immunogenet; 2006 Feb; 33(1):21-4. PubMed ID: 16426238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The expression of microRNA-155 and microRNA-146a and its' clinical value in chronic lymphoproliferative disorders].
    Zhou KS; Yu Z; Yi SH; Li ZJ; Li YF; An G; Zou DH; Qi JY; Zhao YZ; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):656-9. PubMed ID: 22339821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.